Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 1
1976 2
1977 3
1978 1
1980 2
1981 4
1982 1
1983 4
1984 3
1985 5
1986 2
1987 3
1988 2
1989 5
1990 1
1991 2
2002 2
2003 1
2004 1
2006 1
2008 1
2009 1
2010 1
2011 2
2012 1
2013 1
2014 2
2015 1
2017 3
2019 6
2020 6
2021 3
2022 4
2023 4
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

77 results

Results by year

Filters applied: . Clear all
Page 1
Immunogenicity and safety of the adjuvanted recombinant zoster vaccine in adults with haematological malignancies: a phase 3, randomised, clinical trial and post-hoc efficacy analysis.
Dagnew AF, Ilhan O, Lee WS, Woszczyk D, Kwak JY, Bowcock S, Sohn SK, Rodriguez Macías G, Chiou TJ, Quiel D, Aoun M, Navarro Matilla MB, de la Serna J, Milliken S, Murphy J, McNeil SA, Salaun B, Di Paolo E, Campora L, López-Fauqued M, El Idrissi M, Schuind A, Heineman TC, Van den Steen P, Oostvogels L; Zoster-039 study group. Dagnew AF, et al. Among authors: bowcock s. Lancet Infect Dis. 2019 Sep;19(9):988-1000. doi: 10.1016/S1473-3099(19)30163-X. Epub 2019 Aug 6. Lancet Infect Dis. 2019. PMID: 31399377 Clinical Trial.
Time to redefine Myeloma.
Pratt G, Bowcock S, Chantry A, Cook G, Jackson G, Lai M, Low E, Mulholland N, Owen R, Rabin N, Ramasamy K, Snowden JA, Streetly M, Wechalekar A, Yong K, Bird J. Pratt G, et al. Among authors: bowcock s. Br J Haematol. 2015 Oct;171(1):1-10. doi: 10.1111/bjh.13620. Epub 2015 Jul 27. Br J Haematol. 2015. PMID: 26221971 Free article.
Survival trends in elderly myeloma patients.
Jones A, Bowcock S, Rachet B. Jones A, et al. Among authors: bowcock s. Eur J Haematol. 2021 Jan;106(1):126-131. doi: 10.1111/ejh.13530. Epub 2020 Oct 29. Eur J Haematol. 2021. PMID: 33037667
Levofloxacin prophylaxis in patients with newly diagnosed myeloma (TEAMM): a multicentre, double-blind, placebo-controlled, randomised, phase 3 trial.
Drayson MT, Bowcock S, Planche T, Iqbal G, Pratt G, Yong K, Wood J, Raynes K, Higgins H, Dawkins B, Meads D, Hulme CT, Monahan I, Karunanithi K, Dignum H, Belsham E, Neilson J, Harrison B, Lokare A, Campbell G, Hamblin M, Hawkey P, Whittaker AC, Low E, Dunn JA; TEAMM Trial Management Group and Trial Investigators. Drayson MT, et al. Among authors: bowcock s. Lancet Oncol. 2019 Dec;20(12):1760-1772. doi: 10.1016/S1470-2045(19)30506-6. Epub 2019 Oct 23. Lancet Oncol. 2019. PMID: 31668592 Free PMC article. Clinical Trial.
Patient-reported symptoms and diagnostic journey in Multiple Myeloma.
Vijjhalwar R, Song K, Shrestha R, Bowcock S, Sanchez-Santos MT, Ramasamy K, Javaid MK. Vijjhalwar R, et al. Among authors: bowcock s. Front Oncol. 2023 Nov 30;13:1282569. doi: 10.3389/fonc.2023.1282569. eCollection 2023. Front Oncol. 2023. PMID: 38098501 Free PMC article.
Levofloxacin prophylaxis in patients with myeloma - Authors' reply.
Drayson MT, Bowcock S, Planche T, Iqbal G, Pratt G, Yong K, Dunn JA. Drayson MT, et al. Among authors: bowcock s. Lancet Oncol. 2020 Feb;21(2):e69. doi: 10.1016/S1470-2045(20)30020-6. Lancet Oncol. 2020. PMID: 32007200 No abstract available.
COVID symptoms, testing, shielding impact on patient-reported outcomes and early vaccine responses in individuals with multiple myeloma.
Ramasamy K, Sadler R, Jeans S, Varghese S, Turner A, Larham J, Gray N, Barrett J, Bowcock S, Cook G, Kyriakou C, Smith D, Drayson M, Basu S, Moore S, McDonald S, Gooding S, Javaid MK. Ramasamy K, et al. Among authors: bowcock s. Br J Haematol. 2022 Jan;196(1):95-98. doi: 10.1111/bjh.17764. Epub 2021 Aug 2. Br J Haematol. 2022. PMID: 34341984 Free PMC article. No abstract available.
Immune response to COVID-19 vaccination is attenuated by poor disease control and antimyeloma therapy with vaccine driven divergent T-cell response.
Ramasamy K, Sadler R, Jeans S, Weeden P, Varghese S, Turner A, Larham J, Gray N, Carty O, Barrett J, Bowcock S, Oppermann U, Cook G, Kyriakou C, Drayson M, Basu S, Moore S, McDonald S, Gooding S, Javaid MK. Ramasamy K, et al. Among authors: bowcock s. Br J Haematol. 2022 May;197(3):293-301. doi: 10.1111/bjh.18066. Epub 2022 Feb 17. Br J Haematol. 2022. PMID: 35064676 Free PMC article.
77 results